recombinant rsv nanoparticle f vaccine for respiratory syncytial virus

摘要

Summary Recombinant RSV F Nanoparticle F Vaccine for Respiratory Syncytial Virus The present invention is generally related to modified or mutated respiratory syncytial virus (f) fusion proteins and methods for their production and use, including immunogenic compositions such as vaccines for the treatment and / or prevention of rsv infection.